CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 360 participants.

Also called NCT03056222

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 360 participants (enrolled count) (from the registry)
Sponsor
I-Med-Pro GmbH (from the registry)
Registry
  • NCT NCT03056222
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Czechia, Germany, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03056222. Randomized; no masking; primary purpose treatment. Start 2017-04-10 (actual); primary completion 2021-08-16 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation
Acronym
CF²
Condition
Paroxysmal Atrial Fibrillation
Intervention (Device)
Ablation catheter
Lead sponsor
I-Med-Pro GmbH (class: other)

Record details

Record id
cardio:ct-nct03056222
Content hash
247e135a9c537f43ec4d77531f9055c7704ab8b070dec6263662c3fa1cbc9ed5